Maternal blood tests reduce false positives in prenatal screening, study finds

02/27/2014 | NBC News

Prenatal screenings that analyze small amounts of fetal DNA found in maternal blood samples may be more accurate at detecting congenital defects than conventional methods, according to a study in the New England Journal of Medicine. In test results for 2,000 pregnancies, cell-free DNA tests produced false positives at a rate 10 times lower than that of standard screening measures performed later in pregnancy.

View Full Article in:

NBC News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI